Ipriflavone Prevents Bone Loss in Postmenopausal Women
- 1 January 1996
- journal article
- Published by Wolters Kluwer Health in Menopause
- Vol. 3 (1) , 27-32
- https://doi.org/10.1097/00042192-199603010-00006
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Bone density at weight-bearing and nonweight-bearing sites in ballet dancers: the effects of exercise, hypogonadism, and body weightJournal of Clinical Endocrinology & Metabolism, 1994
- Short-term treatment of Paget's disease of bone with ipriflavoneBone and Mineral, 1992
- Effects of ipriflavone on bone remodeling in primary hyperparathyroidismBone and Mineral, 1992
- Cytological and ultrastructural investigation on osteoblastic and preosteoclastic cells grown in vitro in the presence of ipriflavone: Preliminary resultsBone and Mineral, 1992
- Ipriflavone inhibits osteoclast differentiation in parathyroid transplanted parietal bone of ratsCalcified Tissue International, 1992
- Effect of two flavonoid compounds on central nervous system. Analgesic activityLife Sciences, 1991
- Effects of transdermal versus oral hormone replacement therapy on bone density in spine and proximal femur in postmenopausal womenThe Lancet, 1990
- Bone Mass Reduction after Estrogen Deprivation by Long-Acting Gonadotropin-Releasing Hormone Agonists and Its Relation to Pretreatment Serum Concentrations of 1,25-Dihydroxyvitamin D3Journal of Clinical Endocrinology & Metabolism, 1990
- Bone Remodeling and Bone Loss: Understanding The Pathophysiology of OsteoporosisClinical Obstetrics and Gynecology, 1987
- Estrogen therapy arrests bone loss in elderly womenAmerican Journal of Obstetrics and Gynecology, 1987